ClinicalTrials.govpublic full text
Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients
parkinson's disease, mao inhibitors, motor fluctuations, dyskinesia, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 854738
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.